Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Hepatocellular | 6 | 2024 | 386 | 1.750 |
Why?
|
| Liver Neoplasms | 6 | 2024 | 738 | 1.510 |
Why?
|
| Diagnostic Imaging | 5 | 2021 | 469 | 0.980 |
Why?
|
| Magnetic Resonance Imaging | 20 | 2024 | 3362 | 0.760 |
Why?
|
| Prostate | 2 | 2023 | 378 | 0.730 |
Why?
|
| Esophageal Achalasia | 2 | 2015 | 57 | 0.600 |
Why?
|
| Natural Orifice Endoscopic Surgery | 2 | 2015 | 38 | 0.530 |
Why?
|
| Domestic Violence | 1 | 2014 | 24 | 0.480 |
Why?
|
| Preoperative Care | 1 | 2016 | 397 | 0.460 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 237 | 0.440 |
Why?
|
| Tissue Donors | 1 | 2016 | 464 | 0.440 |
Why?
|
| Patient Selection | 1 | 2016 | 686 | 0.420 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 231 | 0.400 |
Why?
|
| Prostatic Neoplasms | 4 | 2023 | 1721 | 0.370 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 849 | 0.340 |
Why?
|
| Neoplasms | 1 | 2022 | 2898 | 0.310 |
Why?
|
| Humans | 35 | 2024 | 86678 | 0.290 |
Why?
|
| Pancreatic Neoplasms | 3 | 2022 | 645 | 0.270 |
Why?
|
| Prognosis | 3 | 2023 | 3680 | 0.260 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2024 | 9 | 0.250 |
Why?
|
| Vascular Diseases | 1 | 2024 | 121 | 0.220 |
Why?
|
| Contrast Media | 3 | 2024 | 1078 | 0.220 |
Why?
|
| Gallbladder Diseases | 1 | 2022 | 22 | 0.220 |
Why?
|
| Radiography, Abdominal | 1 | 2022 | 71 | 0.210 |
Why?
|
| Rectal Neoplasms | 1 | 2023 | 116 | 0.210 |
Why?
|
| Radiology, Interventional | 1 | 2022 | 68 | 0.210 |
Why?
|
| Metatarsal Bones | 1 | 2001 | 6 | 0.200 |
Why?
|
| Fractures, Stress | 1 | 2001 | 10 | 0.200 |
Why?
|
| Biology | 1 | 2021 | 50 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 108 | 0.200 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 318 | 0.190 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 177 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2021 | 241 | 0.180 |
Why?
|
| Kidney Neoplasms | 2 | 2015 | 621 | 0.170 |
Why?
|
| Male | 16 | 2023 | 40988 | 0.170 |
Why?
|
| Abdominal Pain | 1 | 2020 | 137 | 0.170 |
Why?
|
| Mesothelioma | 1 | 2022 | 311 | 0.170 |
Why?
|
| Ultrasonography | 4 | 2016 | 695 | 0.160 |
Why?
|
| Radiation Dosage | 2 | 2022 | 227 | 0.160 |
Why?
|
| Meckel Diverticulum | 1 | 2017 | 6 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 298 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2022 | 2601 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
| Retrospective Studies | 8 | 2024 | 8496 | 0.140 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2015 | 23 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| Fluoroscopy | 1 | 2015 | 119 | 0.130 |
Why?
|
| Common Bile Duct Diseases | 1 | 2014 | 9 | 0.120 |
Why?
|
| Esophagus | 1 | 2015 | 102 | 0.120 |
Why?
|
| Ampulla of Vater | 1 | 2014 | 22 | 0.120 |
Why?
|
| Sensitivity and Specificity | 5 | 2024 | 1992 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2014 | 52 | 0.120 |
Why?
|
| Multidetector Computed Tomography | 1 | 2014 | 55 | 0.120 |
Why?
|
| Lung | 1 | 2020 | 1169 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1271 | 0.110 |
Why?
|
| Bile Duct Neoplasms | 1 | 2014 | 79 | 0.110 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 238 | 0.110 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2012 | 7 | 0.110 |
Why?
|
| Hemoptysis | 1 | 2012 | 24 | 0.110 |
Why?
|
| Radiologists | 2 | 2022 | 46 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 463 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2706 | 0.100 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2012 | 59 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 426 | 0.100 |
Why?
|
| Kidney | 1 | 2016 | 1242 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2012 | 300 | 0.090 |
Why?
|
| Radiography | 2 | 2022 | 813 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 2262 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 1204 | 0.080 |
Why?
|
| Liver | 2 | 2024 | 1230 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 663 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1830 | 0.070 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2006 | 93 | 0.070 |
Why?
|
| Thyroid Nodule | 1 | 2006 | 51 | 0.070 |
Why?
|
| Specimen Handling | 1 | 2006 | 98 | 0.070 |
Why?
|
| Middle Aged | 8 | 2022 | 25040 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2015 | 2207 | 0.070 |
Why?
|
| Female | 7 | 2015 | 44550 | 0.060 |
Why?
|
| Pancreatic Cyst | 1 | 2002 | 28 | 0.050 |
Why?
|
| Adult | 7 | 2020 | 25659 | 0.050 |
Why?
|
| Interdisciplinary Research | 1 | 2022 | 6 | 0.050 |
Why?
|
| Water | 2 | 2020 | 277 | 0.050 |
Why?
|
| Meningeal Neoplasms | 1 | 2002 | 61 | 0.050 |
Why?
|
| Ascites | 1 | 2022 | 56 | 0.050 |
Why?
|
| Reference Standards | 1 | 2022 | 159 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2022 | 86 | 0.050 |
Why?
|
| Foot Injuries | 1 | 2001 | 10 | 0.050 |
Why?
|
| Remission Induction | 1 | 2023 | 722 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2022 | 153 | 0.050 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2001 | 33 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2023 | 7998 | 0.050 |
Why?
|
| Consensus | 1 | 2022 | 336 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2001 | 220 | 0.050 |
Why?
|
| Chemoradiotherapy | 1 | 2023 | 301 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2023 | 533 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2001 | 255 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 840 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 395 | 0.040 |
Why?
|
| Melanoma | 1 | 2002 | 459 | 0.040 |
Why?
|
| Living Donors | 1 | 2021 | 339 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 294 | 0.040 |
Why?
|
| Pain | 1 | 2001 | 391 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2023 | 1939 | 0.040 |
Why?
|
| Observer Variation | 2 | 2014 | 603 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2001 | 398 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1313 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2015 | 87 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 62 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2001 | 763 | 0.030 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2014 | 11 | 0.030 |
Why?
|
| Common Bile Duct | 1 | 2014 | 19 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 62 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 462 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 1585 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2014 | 34 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 96 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 4214 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2015 | 328 | 0.030 |
Why?
|
| Stroke | 1 | 2001 | 965 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2014 | 429 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 2012 | 72 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 467 | 0.020 |
Why?
|
| Brain | 1 | 2001 | 2216 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1566 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 6513 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2012 | 563 | 0.020 |
Why?
|
| Aged | 3 | 2015 | 18423 | 0.020 |
Why?
|
| Biomarkers | 1 | 2013 | 1718 | 0.020 |
Why?
|
| Hashimoto Disease | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cytodiagnosis | 1 | 2006 | 42 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2006 | 158 | 0.020 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2002 | 9 | 0.010 |
Why?
|
| Laminectomy | 1 | 2002 | 27 | 0.010 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2002 | 48 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2002 | 79 | 0.010 |
Why?
|
| Diffusion | 1 | 2001 | 93 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2006 | 408 | 0.010 |
Why?
|
| Pancreas | 1 | 2002 | 239 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2001 | 482 | 0.010 |
Why?
|
| Age Factors | 1 | 2001 | 1852 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 5214 | 0.010 |
Why?
|